NMR-based Lipoprotein Analysis for Patients With Advanced Hypercholesterolemia Undergoing Chronic Lipoprotein Apheresis or PCSK9-inhibitor Therapy (NAPALI)-Study

Therapeutic Apheresis and Dialysis - United Kingdom
doi 10.1111/1744-9987.12792

Related search